Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke
Standard
Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke. / Fiehler, Jens; Nawka, Marie Teresa; Meyer, Lukas.
in: CURR OPIN NEUROL, Jahrgang 35, Nr. 1, 01.02.2022, S. 18-23.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke
AU - Fiehler, Jens
AU - Nawka, Marie Teresa
AU - Meyer, Lukas
N1 - Copyright © 2021 Wolters Kluwer Health, Inc. All rights resereved.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - PURPOSE OF REVIEW: Although endovascular treatment (EVT) is the gold standard for treating acute stroke patients with large vessel occlusion (LVO), multiple challenges in decision-making for specific conditions persist. Recent evidence on a selection of patient subgroups will be discussed in this narrative review.RECENT FINDINGS: Two randomized controlled trials (RCTs) have been published in EVT of basilar artery occlusion (BAO). Large single arm studies showed promising results in Patients with low Alberta stroke program early CT score (ASPECTS) and more distal vessel occlusions. Recent data confirm patients with low National Institutes of Health Stroke Scale (NIHSS) despite LVO to represent a heterogeneous and challenging patient group.SUMMARY: The current evidence does not justify withholding EVT from BAO patients as none of the RCTs showed any signal of superiority of BMT alone vs. EVT. Patients with low ASPECTS, more distal vessel occlusions and patients with low NIHSS scores should be included into RCTs if possible. Without participation in a RCT, patients should be selected for EVT based on age, severity and type of neurological impairment, time since symptom onset, location of the ischaemic lesion and perhaps also results of advanced imaging.
AB - PURPOSE OF REVIEW: Although endovascular treatment (EVT) is the gold standard for treating acute stroke patients with large vessel occlusion (LVO), multiple challenges in decision-making for specific conditions persist. Recent evidence on a selection of patient subgroups will be discussed in this narrative review.RECENT FINDINGS: Two randomized controlled trials (RCTs) have been published in EVT of basilar artery occlusion (BAO). Large single arm studies showed promising results in Patients with low Alberta stroke program early CT score (ASPECTS) and more distal vessel occlusions. Recent data confirm patients with low National Institutes of Health Stroke Scale (NIHSS) despite LVO to represent a heterogeneous and challenging patient group.SUMMARY: The current evidence does not justify withholding EVT from BAO patients as none of the RCTs showed any signal of superiority of BMT alone vs. EVT. Patients with low ASPECTS, more distal vessel occlusions and patients with low NIHSS scores should be included into RCTs if possible. Without participation in a RCT, patients should be selected for EVT based on age, severity and type of neurological impairment, time since symptom onset, location of the ischaemic lesion and perhaps also results of advanced imaging.
KW - Brain Ischemia/drug therapy
KW - Endovascular Procedures
KW - Humans
KW - Ischemic Stroke
KW - Stroke/therapy
KW - Thrombectomy
KW - Thrombolytic Therapy
KW - Treatment Outcome
U2 - 10.1097/WCO.0000000000001006
DO - 10.1097/WCO.0000000000001006
M3 - SCORING: Review article
C2 - 34812746
VL - 35
SP - 18
EP - 23
JO - CURR OPIN NEUROL
JF - CURR OPIN NEUROL
SN - 1350-7540
IS - 1
ER -